Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Agilent Technologies Inc. buy Luise1

Start price
€43.25
10.06.14 / 50%
Target price
€75.00
10.12.14
Performance (%)
6.43%
End price
€33.26
10.12.14
Summary
This prediction ended on 10.12.14 with a price of €33.26. The BUY prediction by Luise1 finished with a performance of 6.43%. Luise1 has 50% into this prediction

Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."

Performance without dividends (%)
Name 1w 1m 1y 3y
Agilent Technologies Inc. -0.047% -0.047% 4.459% 15.502%
iShares Core DAX® -0.992% -3.231% 11.661% 16.545%
iShares Nasdaq 100 -0.225% -3.339% 36.491% 43.334%
iShares Nikkei 225® -0.736% -7.859% 18.597% 4.253%
iShares S&P 500 -0.509% -2.979% 26.341% 40.911%

Comments by Luise1 for this prediction

In the thread Agilent Technologies Inc. diskutieren
Prediction Buy
Perf. (%) 6.43%
Target price 75.000
Change
Ends at 10.12.14

Weltmarktführer

Irgendwann reichts! Was manche Analysten schreiben, ist völlig daneben. Diese Firma hat soeben

Ein Medikament auf den Markt gebracht, das die kranken Menschen von ihrer Hpatitis heilt und dies 

Völlig ohne  Nebenwirkungen! Nachteil: die Behandlung geht massiv an die Geldbörse. Fall ich am abnippeln bin und ein paar Mark (84000 Dollar) habe, dann werd ich mir dies leisten bevor ich zu Manitu geh....

Strong buy....kann dies leider nicht anders beantworten! Buy, buy Gilead...

Prediction Buy
Perf. (%) 6.43%
Target price 75.000
Change
Ends at 10.12.14

(Laufzeit überschritten)